On-Demand Webcast

Share

Program Content

Activities

  • TROP2 and HER3 ADCs
    Therapeutics Targeting TROP2 and HER3: Perspective on the Next Precision Treatment Advances Across Solid Tumors
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 23, 2023

    Expires: May 22, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.